• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨转移患者癌症和非癌症死亡率的综合分析:一项基于人群的研究。

Comprehensive analysis of cancer and non-cancer mortality in patients with bone metastases: A population-based study.

作者信息

Yan Xia, Liu Hongyu, Bai Xueqi, Xu Jin, Lou Xiaojun, Wang Lai

机构信息

Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.

Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.

出版信息

J Bone Oncol. 2025 Aug 18;54:100708. doi: 10.1016/j.jbo.2025.100708. eCollection 2025 Oct.

DOI:10.1016/j.jbo.2025.100708
PMID:40896774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12398215/
Abstract

PURPOSE

To characterize causes of death in patients with bone metastases and to support data-driven approaches to survivorship planning and clinical decision-making in this population.

METHODS

Using data from the SEER registry (2010-2021), we identified 186,404 patients with newly diagnosed bone metastases. Causes of death were classified as related to the cancer-specific, non-cancer, or subsequent cancer. Standardized mortality ratios (SMRs) were calculated to assess excess non-cancer mortality relative to the general population.

RESULTS

During follow-up, 133,393 patients (71.5 %) died from the primary cancer, 11,062 (5.9 %) from non-cancer causes, and 929 (0.5 %) from other malignancies. Although cancer remained the predominant cause of death, non-cancer mortality increased over time (from 6.3 % in 2010 to 9.5 % in 2021). Cardiovascular disease, COPD, and cerebrovascular events were the most common non-cancer causes. The greatest excess mortality was observed for HIV-related infection conditions (SMR: 13.24), septicemia (10.60), suicide (6.68), and pneumonia/influenza (6.04).

CONCLUSION

Non-cancer mortality is an increasingly important contributor to death among patients with bone metastases, underscoring the need for targeted prevention strategies for infections, cardiovascular disease, and other avoidable causes in this vulnerable population.

摘要

目的

明确骨转移患者的死亡原因,并支持基于数据的生存规划方法及该人群的临床决策。

方法

利用监测、流行病学和最终结果(SEER)登记处(2010 - 2021年)的数据,我们确定了186,404例新诊断为骨转移的患者。死亡原因分为与癌症相关、非癌症或后续癌症。计算标准化死亡率(SMR)以评估相对于一般人群的非癌症超额死亡率。

结果

在随访期间,133,393例患者(71.5%)死于原发性癌症,11,062例(5.9%)死于非癌症原因,929例(0.5%)死于其他恶性肿瘤。尽管癌症仍然是主要的死亡原因,但非癌症死亡率随时间增加(从2010年的6.3%增至2021年的9.5%)。心血管疾病、慢性阻塞性肺疾病(COPD)和脑血管事件是最常见的非癌症原因。在与HIV相关的感染情况(SMR:13.24)、败血症(10.60)、自杀(6.68)和肺炎/流感(6.04)中观察到最高的超额死亡率。

结论

非癌症死亡率在骨转移患者的死亡中所占比例日益增加,这突出表明需要针对这一脆弱人群制定针对感染、心血管疾病和其他可避免原因的预防策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cb/12398215/b132a76207d3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cb/12398215/20ac0cfadfc0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cb/12398215/20779e154b90/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cb/12398215/b132a76207d3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cb/12398215/20ac0cfadfc0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cb/12398215/20779e154b90/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cb/12398215/b132a76207d3/gr3.jpg

相似文献

1
Comprehensive analysis of cancer and non-cancer mortality in patients with bone metastases: A population-based study.骨转移患者癌症和非癌症死亡率的综合分析:一项基于人群的研究。
J Bone Oncol. 2025 Aug 18;54:100708. doi: 10.1016/j.jbo.2025.100708. eCollection 2025 Oct.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
5
Causes of death among patients with primary malignant brain tumors in the US from 2000 to 2021.2000年至2021年美国原发性恶性脑肿瘤患者的死亡原因。
Eur J Surg Oncol. 2025 Aug;51(8):110223. doi: 10.1016/j.ejso.2025.110223. Epub 2025 Jun 8.
6
All-Cause Mortality and Specific Causes of Death in Autism: A Nationwide Analysis.自闭症患者的全因死亡率及特定死因:一项全国性分析。
Autism Adulthood. 2025 Feb 5;7(1):81-92. doi: 10.1089/aut.2023.0103. eCollection 2025 Feb.
7
Influenza vaccines in immunosuppressed adults with cancer.癌症免疫抑制成人中的流感疫苗
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD008983. doi: 10.1002/14651858.CD008983.pub3.
8
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
9
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
10
Bisphosphonates for breast cancer.用于乳腺癌的双膦酸盐类药物。
Cochrane Database Syst Rev. 2005 Jul 20(3):CD003474. doi: 10.1002/14651858.CD003474.pub2.

本文引用的文献

1
Suicide and Suicidal Ideation Among Survivors of Childhood Cancer: A Systematic Review and Meta-Analysis.儿童癌症幸存者中的自杀及自杀意念:一项系统综述与荟萃分析
JAMA Netw Open. 2025 Feb 3;8(2):e2457544. doi: 10.1001/jamanetworkopen.2024.57544.
2
How the bone microenvironment shapes the pre-metastatic niche and metastasis.骨微环境如何塑造转移前生态位和转移。
Nat Cancer. 2024 Dec;5(12):1800-1814. doi: 10.1038/s43018-024-00854-6. Epub 2024 Dec 13.
3
Overall and cause-specific mortality among patients diagnosed with gastric precancerous lesions in Sweden between 1979 and 2014: an observational cohort study.
1979 年至 2014 年间瑞典被诊断为胃癌前病变患者的总体和特定病因死亡率:一项观察性队列研究。
BMC Med. 2024 Aug 15;22(1):333. doi: 10.1186/s12916-024-03554-1.
4
Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study.分化型甲状腺癌伴远处转移患者的生存预后:一项 SEER 基于人群的研究。
Thyroid. 2024 Jul;34(7):837-845. doi: 10.1089/thy.2023.0709. Epub 2024 Jul 1.
5
Causes of death among people living with metastatic cancer.转移性癌症患者的死因
Nat Commun. 2024 Feb 19;15(1):1519. doi: 10.1038/s41467-024-45307-x.
6
Mechanisms of Organ-Specific Metastasis of Breast Cancer.乳腺癌器官特异性转移的机制。
Cold Spring Harb Perspect Med. 2023 Nov 1;13(11):a041326. doi: 10.1101/cshperspect.a041326.
7
Cancer-specific survival and metastasis in pancreatic mucinous cystadenocarcinoma: A SEER-based cohort study.胰腺黏液性囊腺癌的癌症特异性生存率和转移情况:一项基于监测、流行病学和最终结果(SEER)数据库的队列研究
Front Oncol. 2022 Oct 20;12:985184. doi: 10.3389/fonc.2022.985184. eCollection 2022.
8
Non-cancer Causes of Death Following Initial Synchronous Bone Metastasis in Cancer Patients.癌症患者初次发生同步骨转移后的非癌症死亡原因
Front Med (Lausanne). 2022 Jun 2;9:899544. doi: 10.3389/fmed.2022.899544. eCollection 2022.
9
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety.癌症患者的 COVID-19 疫苗:免疫原性、疗效和安全性。
Nat Rev Clin Oncol. 2022 Jun;19(6):385-401. doi: 10.1038/s41571-022-00610-8. Epub 2022 Mar 11.
10
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.新冠疫苗在免疫功能低下患者中的有效性:系统评价和荟萃分析。
BMJ. 2022 Mar 2;376:e068632. doi: 10.1136/bmj-2021-068632.